Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Naylor

Showing results (141-150 of 688) with videos related to

Pageof 69
Sort By:
The Veterinary Record|December 18, 1982
Glomerular lesions associated with infestation with Toxocara catiJ M Hamilton, J Naylor, A Weatherley
Physiotherapy|October 18, 2022
"You've broken the patient": Physiotherapists' lived experience of incivility within the healthcare team - An Interpretative Phenomenological AnalysisMichelle J Naylor, Christopher Boyes, Clare Killingback
British Journal of Pharmacology|January 1, 1980
On the importance of mesolimbic mechanisms for the control of apomorphine induced climbing behaviour in the mouse [proceedings]B Costall, R J Naylor, V Nohria
Arzneimittel-Forschung|July 1, 1972
The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agentsB Costall, R J Naylor, T Wright
British Journal of Sports Medicine|October 17, 1998
Barriers to physical activity promotion by general practitioners and practice nursesJ McKenna, P J Naylor, N McDowell
British Poultry Science|December 30, 2004
Selenium supplementation affects broiler growth performance, meat yield and feather coverageM Choct, A J Naylor, N Reinke
International Pharmacopsychiatry|January 1, 1981
Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervationV Nohria, B Costall, R J Naylor
British Journal of Pharmacology|June 1, 1978
Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings]B Costall, R J Naylor, V Nohria
Nutrition and Health|January 1, 1985
A double blind placebo controlled trial of ascorbic acid in obesityG J Naylor, L Grant, C Smith
Psychopharmacologia|January 1, 1975
Nomifensine: a potent dopaminergic agonist of antiparkinson potentialB Costall, D M Kelly, R J Naylor
Pageof 69

Showing results (141-150 of 688) with videos related to

Sort By:
Pageof 69
The Veterinary Record|December 18, 1982
Glomerular lesions associated with infestation with Toxocara catiJ M Hamilton, J Naylor, A Weatherley
Physiotherapy|October 18, 2022
"You've broken the patient": Physiotherapists' lived experience of incivility within the healthcare team - An Interpretative Phenomenological AnalysisMichelle J Naylor, Christopher Boyes, Clare Killingback
British Journal of Pharmacology|January 1, 1980
On the importance of mesolimbic mechanisms for the control of apomorphine induced climbing behaviour in the mouse [proceedings]B Costall, R J Naylor, V Nohria
Arzneimittel-Forschung|July 1, 1972
The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agentsB Costall, R J Naylor, T Wright
British Journal of Sports Medicine|October 17, 1998
Barriers to physical activity promotion by general practitioners and practice nursesJ McKenna, P J Naylor, N McDowell
British Poultry Science|December 30, 2004
Selenium supplementation affects broiler growth performance, meat yield and feather coverageM Choct, A J Naylor, N Reinke
International Pharmacopsychiatry|January 1, 1981
Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervationV Nohria, B Costall, R J Naylor
British Journal of Pharmacology|June 1, 1978
Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings]B Costall, R J Naylor, V Nohria
Nutrition and Health|January 1, 1985
A double blind placebo controlled trial of ascorbic acid in obesityG J Naylor, L Grant, C Smith
Psychopharmacologia|January 1, 1975
Nomifensine: a potent dopaminergic agonist of antiparkinson potentialB Costall, D M Kelly, R J Naylor
Pageof 69